A public event held on 1 December at which clinicians, patient groups and other interested parties will be invited to give their views on the current system, and on proposals for future licensing Gathering the opinions of experts in cancer genetics and consultants involved in the care of children where an HLA tissue-matched sibling is the only available treatment.